Cite

HARVARD Citation

    Jiang, H. et al. (2019). Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer. Journal of the National Cancer Institute. pp. 409-418. [Online]. 
  
Back to record